Wave Life Sciences Ltd. financial data

Symbol
WVE on Nasdaq
Location
Singapore, Singapore
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 10 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 274% % 105%
Debt-to-equity 71% % -82.9%
Return On Equity -75.61% % 73%
Return On Assets -43% % 19%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 167,181,784 shares 9.6%
Common Stock, Shares, Outstanding 160,288,481 shares 8%
Entity Public Float $488,707,919 USD 89%
Common Stock, Value, Issued $1,223,721,000 USD 7.4%
Weighted Average Number of Shares Outstanding, Basic 167,739,208 shares 27%
Weighted Average Number of Shares Outstanding, Diluted 167,739,208 shares 27%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $8,699,000 USD -55.82%
Research and Development Expense $174,610,000 USD 17%
General and Administrative Expense $70,569,000 USD 25%
Operating Income (Loss) $-135,949,000 USD 11%
Nonoperating Income (Expense) $14,003,000 USD 47%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $-121,946,000 USD 14%
Income Tax Expense (Benefit) $0 USD
Net Income (Loss) Attributable to Parent $-121,946,000 USD 14%
Earnings Per Share, Basic 0 USD/shares 40%
Earnings Per Share, Diluted 0 USD/shares 40%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $196,218,000 USD -36.9%
Accounts Receivable, after Allowance for Credit Loss, Current $10,000,000 USD
Other Assets, Current $2,617,000 USD -12.62%
Assets, Current $215,488,000 USD -33.6%
Property, Plant and Equipment, Net $8,196,000 USD -25%
Operating Lease, Right-of-Use Asset $13,876,000 USD -27.42%
Other Assets, Noncurrent $22,000 USD
Assets $241,378,000 USD -32.67%
Accounts Payable, Current $14,490,000 USD 13%
Employee-related Liabilities, Current $11,139,000 USD 14%
Accrued Liabilities, Current $4,591,000 USD 63%
Contract with Customer, Liability, Current $46,525,000 USD -65.77%
Liabilities, Current $85,896,000 USD -49.69%
Contract with Customer, Liability, Noncurrent $11,681,000 USD -36.82%
Operating Lease, Liability, Noncurrent $11,378,000 USD -42.45%
Liabilities $108,955,000 USD -47.87%
Accumulated Other Comprehensive Income (Loss), Net of Tax $-190,000 USD -19.5%
Retained Earnings (Accumulated Deficit) $-1,273,057,000 USD -10.59%
Stockholders' Equity Attributable to Parent $124,549,000 USD -12.07%
Liabilities and Equity $241,378,000 USD -32.67%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $-63,039,000 USD -88.56%
Net Cash Provided by (Used in) Financing Activities $4,155,000 USD -71.36%
Net Cash Provided by (Used in) Investing Activities $-165,000 USD 60%
Common Stock, Shares, Issued 160,288,481 shares 8%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $-58,991,000 USD -203.87%
Deferred Tax Assets, Valuation Allowance $272,313,000 USD 10%
Deferred Tax Assets, Gross $276,978,000 USD 9.3%
Operating Lease, Liability $25,404,000 USD -20.9%
Depreciation $875,000 USD -16.03%
Payments to Acquire Property, Plant, and Equipment $165,000 USD -60.43%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $-121,977,000 USD 14%
Lessee, Operating Lease, Liability, to be Paid $29,048,000 USD -24.27%
Property, Plant and Equipment, Gross $56,457,000 USD 1.2%
Operating Lease, Liability, Current $8,394,000 USD 13%
Lessee, Operating Lease, Liability, to be Paid, Year Two $9,584,000 USD -0.07%
Lessee, Operating Lease, Liability, to be Paid, Year One $9,591,000 USD 3%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $3,644,000 USD -41.61%
Lessee, Operating Lease, Liability, to be Paid, Year Three $8,987,000 USD -6.23%
Deferred Tax Assets, Operating Loss Carryforwards $177,639,000 USD 3%
Unrecognized Tax Benefits $20,798,000 USD 32%
Lessee, Operating Lease, Liability, to be Paid, Year Four $886,000 USD -90.14%
Additional Paid in Capital $174,075,000 USD 14%
Deferred Tax Assets, Net of Valuation Allowance $4,665,000 USD -24.64%
Share-based Payment Arrangement, Expense $4,953,000 USD 72%